comparemela.com

Latest Breaking News On - Surface ophthalmics - Page 2 : comparemela.com

Harrow Health, Inc. (NASDAQ:HROW) CEO Buys $104,310.00 in Stock

Harrow Health, Inc. (NASDAQ:HROW – Get Free Report) CEO Mark L. Baum acquired 9,000 shares of the firm’s stock in a transaction on Friday, March 22nd. The shares were bought at an average cost of $11.59 per share, for a total transaction of $104,310.00. Following the completion of the acquisition, the chief executive officer now […]

Markl-baum
Surface-ophthalmics-inc
Rice-hall-james-associates
Harrow-health-company-profile
Jump-financial
Stifel-financial-corp
Harrow-health
Kennedy-capital-management
Pharmaceuticals-inc
Nasdaq
News-ratings-for-harrow-health-daily

Harrow Health, Inc. Expected to Post Q1 2024 Earnings of ($0.25) Per Share (NASDAQ:HROW)

Harrow Health, Inc. Expected to Post Q1 2024 Earnings of ($0.25) Per Share (NASDAQ:HROW)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Markl-baum
Harrow-health-trading
Institutional-trading-of-harrow-health
Blackrock-inc
Vanguard-group-inc
Pharmaceuticals-inc
Harrow-health
Opaleye-management-inc
Morgan-stanley
Insider-activity-at-harrow-health
Securities-exchange-commission

Harrow Health, Inc. (NASDAQ:HROW) Expected to Earn Q1 2024 Earnings of ($0.25) Per Share

Harrow Health, Inc. (NASDAQ:HROW – Free Report) – Investment analysts at B. Riley issued their Q1 2024 earnings per share estimates for shares of Harrow Health in a research note issued to investors on Thursday, March 21st. B. Riley analyst M. Mamtani forecasts that the company will post earnings of ($0.25) per share for the […]

Eton-pharmaceuticals-inc
Goldman-sachs-group-inc
Harrow-health
Nasdaq
Nuveen-asset-management
Harrow-health-stock
Barclays-plc
Surface-ophthalmics-inc
Pricet-rowe-associates-inc
News-ratings-for-harrow-health-daily
Vanguard-group-inc

Paradigm Capital Management Inc. NY Acquires New Position in Harrow Health, Inc. (NASDAQ:HROW)

Paradigm Capital Management Inc. NY Acquires New Position in Harrow Health, Inc. (NASDAQ:HROW)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Harrow-health-inc
Quarter-for-harrow-health
News-ratings-for-harrow-health-daily
Pharmaceuticals-inc
Surface-ophthalmics-inc
Harrow-health
Nasdaq
Prelude-capital-management
Eton-pharmaceuticals-inc
Harrow-health-trading
Wasatch-advisors-inc

Harrow, Inc. Announces Board of Director Appointments

Harrow announced the appointments of Adrienne Graves, Ph.D., and Lauren Silvernail to the Company?s Board of Directors, effective immediately. Harrow?s Board now consists of six members. Dr. Adrienne.

United-states
Michigan
California
Glenwood
Berkeley
Paris
France-general
France
Stanford-university
American
Los-angeles
Lauren-silvernail

vimarsana © 2020. All Rights Reserved.